Cargando…

Identification and Characterization of USP7 Targets in Cancer Cells

The ubiquitin specific protease, USP7, regulates multiple cellular pathways relevant for cancer through its ability to bind and sometimes stabilize specific target proteins through deubiquitylation. To gain a more complete profile of USP7 interactions in cancer cells, we performed affinity purificat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Georges, Anna, Marcon, Edyta, Greenblatt, Jack, Frappier, Lori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203733/ https://www.ncbi.nlm.nih.gov/pubmed/30367141 http://dx.doi.org/10.1038/s41598-018-34197-x

Ejemplares similares

Author Correction: Identification and Characterization of USP7 Targets in Cancer Cells
por: Georges, Anna, et al.
Publicado: (2019)

USP7 Regulates Cytokinesis through FBXO38 and KIF20B
por: Georges, Anna, et al.
Publicado: (2019)

Crystal Structure of USP7 Ubiquitin-like Domains with an ICP0 Peptide Reveals a Novel Mechanism Used by Viral and Cellular Proteins to Target USP7
por: Pfoh, Roland, et al.
Publicado: (2015)

USP7/HAUSP Promotes the Sequence-Specific DNA Binding Activity of p53
por: Sarkari, Feroz, et al.
Publicado: (2010)

Epstein-Barr Virus BGLF2 commandeers RISC to interfere with cellular miRNA function
por: Campbell, Ashley M., et al.
Publicado: (2022)

The Herpesvirus Associated Ubiquitin Specific Protease, USP7, Is a Negative Regulator of PML Proteins and PML Nuclear Bodies
por: Sarkari, Feroz, et al.
Publicado: (2011)

Changes in SUMO-modified proteins in Epstein-Barr virus infection identifies reciprocal regulation of TRIM24/28/33 complexes and the lytic switch BZLF1
por: De La Cruz-Herrera, Carlos F., et al.
Publicado: (2023)

USP7: Novel Drug Target in Cancer Therapy
por: Wang, Zhiru, et al.
Publicado: (2019)

USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation
por: Palazón‐Riquelme, Pablo, et al.
Publicado: (2018)

Targeting melanoma residual disease by USP7
por: Vishnoi, Monika, et al.
Publicado: (2018)

USP7 substrates identified by proteomics analysis reveal the specificity of USP7
por: Nie, Litong, et al.
Publicado: (2022)

CDDO-Me reveals USP7 as a novel target in ovarian cancer cells
por: Qin, Dongjun, et al.
Publicado: (2016)

Highlights in USP7 inhibitors for cancer treatment
por: Oliveira, Rita I., et al.
Publicado: (2022)

Epstein-Barr virus BORF2 inhibits cellular APOBEC3B to preserve viral genome integrity
por: Cheng, Adam Z., et al.
Publicado: (2018)

Selective Inhibition of USP7
por: Menard, Robert, et al.
Publicado: (2012)

Contributions of Epstein–Barr Nuclear Antigen 1 (EBNA1) to Cell Immortalization and Survival
por: Frappier, Lori
Publicado: (2012)

Inhibition of USP7 upregulates USP22 and activates its downstream cancer-related signaling pathways in human cancer cells
por: Zhang, Keqiang, et al.
Publicado: (2023)

USP7 deubiquitinates and stabilizes EZH2 in prostate cancer cells
por: Lee, Jae Eun, et al.
Publicado: (2020)

Targeting deubiquitinase USP28 for cancer therapy
por: Wang, Xiaofang, et al.
Publicado: (2018)

Targeting Ubiquitin-Specific Protease 7 (USP7) in Cancer: A New Insight to Overcome Drug Resistance
por: Lu, Jiabin, et al.
Publicado: (2021)

Targeting USP-7 by a Novel Fluorinated 5-Pyrazolyl-Urea Derivative
por: Morretta, Elva, et al.
Publicado: (2023)

The Epstein-Barr Virus EBNA1 Protein
por: Frappier, Lori
Publicado: (2012)

Epstein-Barr virus: Current questions and challenges
por: Frappier, Lori
Publicado: (2021)

USP7 Inhibitors in Cancer Immunotherapy: Current Status and Perspective
por: Korenev, Georgiy, et al.
Publicado: (2022)

Molecular mechanism for the substrate recognition of USP7
por: Cheng, Jingdong, et al.
Publicado: (2015)

Fbw7 and Usp28 – enemies and allies
por: Taranets, Lyudmyla, et al.
Publicado: (2015)

TIP60 governs the auto-ubiquitination of UHRF1 through USP7 dissociation from the UHRF1/USP7 complex
por: Ahmad, Tanveer, et al.
Publicado: (2021)

Emerging insights into HAUSP (USP7) in physiology, cancer and other diseases
por: Bhattacharya, Seemana, et al.
Publicado: (2018)

Characterization of alternatively spliced products and tissue-specific isoforms of USP28 and USP25
por: Valero, Rebeca, et al.
Publicado: (2001)

Functional characterization of RebL1 highlights the evolutionary conservation of oncogenic activities of the RBBP4/7 orthologue in Tetrahymena thermophila
por: Nabeel-Shah, Syed, et al.
Publicado: (2021)

Kinetic analysis of multistep USP7 mechanism shows critical role for target protein in activity
por: Kim, Robbert Q., et al.
Publicado: (2019)

USP7 targeting modulates anti-tumor immune response by reprogramming Tumor-associated Macrophages in Lung Cancer
por: Dai, Xiaomeng, et al.
Publicado: (2020)

USP7 Is a Master Regulator of Genome Stability
por: Valles, Gabrielle J., et al.
Publicado: (2020)

FAM188B enhances cell survival via interaction with USP7
por: Choi, Eun-Seok, et al.
Publicado: (2018)

USP7 deubiquitinates and stabilizes NOTCH1 in T-cell acute lymphoblastic leukemia
por: Shan, Huizhuang, et al.
Publicado: (2018)

USP7 inactivation suppresses APC-mutant intestinal hyperproliferation and tumor development
por: Novellasdemunt, Laura, et al.
Publicado: (2023)

USP10 as a Potential Therapeutic Target in Human Cancers
por: Tao, Li, et al.
Publicado: (2022)

EPEN-03. USP7 is an interaction partner of EZHIP and potential druggable target in PFA ependymomas
por: Jenseit, Anne, et al.
Publicado: (2022)

Neuroinflammation inhibition by small-molecule targeting USP7 noncatalytic domain for neurodegenerative disease therapy
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

Evolution of the highly networked deubiquitinating enzymes USP4, USP15, and USP11
por: Vlasschaert, Caitlyn, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4ikckhfjv74e0kgj0o9erbol4t